Vaccine will not be released for mass use unless proven immunogenic: Serum Institute
Chennai: Vaccine development company Serum Institute, India on Tuesday said the Covidshield vaccine will not be released for mass use unless it is proven immunogenic, and safe.
The company also said the serious adverse event (SAE) that…